Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT03358290. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of JTE-051 Administered for 12 Weeks in Subjects With Moderate to Severe Plaque Psoriasis (CLEAR-PS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study to evaluate the efficacy, safety, tolerability and pharmacokinetics of JTE-051 administered for 12 weeks in subjects with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT03358290
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 13 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2017
- Primary completion
- Oct 28, 2018
- Completion
- Oct 28, 2018
- Last update posted
- Aug 5, 2021
2017 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| University of South Florida - Hospital | Tampa | Florida | 33612 | — |
| Atlanta Dermatology Vein and Research Center LLC | Alpharetta | Georgia | 30022 | — |
| Advanced Medical Research, PC | Sandy Springs | Georgia | 30328 | — |
| Advanced Clinical Research - Dermatology Center of Canyon County | Nampa | Idaho | 83651 | — |
| Clinical Research Advantage, Inc. | Evansville | Indiana | 47714 | — |
| Kansas City Dermatology P.A. | Overland Park | Kansas | 66215-2309 | — |
| Forest Hills Dermatology Group | Forest Hills | New York | 11375 | — |
| Radiant Research, Inc. | Anderson | South Carolina | 29621 | — |
| Clinical Research Center of the Carolinas | Charleston | South Carolina | 29407 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03358290, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2021 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03358290 live on ClinicalTrials.gov.